Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Portola Pharmaceuticals begins enrollment in Phase 3 study for Xarelto/andexanet alfa combo
The Fly on the Wall
Monday, May 12, 2014 - 9:12am
tags:
Portola Pharmaceuticals, Xarelto, Bayer, Janssen, andexanet alfa
Allergan board unanimously rejects cash-stock takeover offer from Valeant Pharma
Yahoo/AP
Monday, May 12, 2014 - 9:08am
tags:
Allergan, Valeant Pharmaceuticals, M&A
AstraZeneca Continues To Benefit From Pfizer Courtship
Seeking Alpha
Monday, May 12, 2014 - 8:24am
tags:
AstraZeneca, Pfizer
Biogen, Sobi pledge hemophilia drug donation in developing world
Yahoo/Reuters
Monday, May 12, 2014 - 8:21am
tags:
Biogen Idec, hemophilia, Swedish Orphan Biovitrum
What Could Pfizer-AstraZeneca Be Like?
Motley Fool
Monday, May 12, 2014 - 8:18am
tags:
Pfizer, M&A, AstraZeneca
Spectrum Pharma Up on Q1 Earnings
Yahoo/Zacks.com
Monday, May 12, 2014 - 8:14am
tags:
Spectrum Pharmaceuticals, earnings
Bristol-Myers: Nivolumab Holds Good Potential
Seeking Alpha
Monday, May 12, 2014 - 8:12am
tags:
nivolumab, Bristol-Myers Squibb
Shire buys Lumena Pharma for at least $260 million
Yahoo/Reuters
Monday, May 12, 2014 - 8:10am
tags:
Shire, Lumena Pharmaceuticals, M&A
Pfizer CEO Faces U.K. Panel as Resistance to Bid Hardens
Bloomberg
Monday, May 12, 2014 - 8:10am
tags:
Pfizer, UK, AstraZeneca, M&A, Ian Read
AstraZeneca CEO confident in pipeline of breakthrough drugs, Independent says
The Fly on the Wall
Monday, May 12, 2014 - 8:08am
tags:
Pascal Soriot, Pharma CEOs, AstraZeneca
U.K. Pursues More Guarantees From Pfizer Over AstraZeneca
Bloomberg
Sunday, May 11, 2014 - 11:34am
tags:
Pfizer, AstraZeneca, M&A
Got Dividend? This Biotech Just Initiated a Nearly 4% Yield!
Motley Fool
Sunday, May 11, 2014 - 11:32am
tags:
Theravance
Under fire, Pfizer hits back as it weighs next Astra move
Yahoo/Reuters
Sunday, May 11, 2014 - 11:31am
tags:
Pfizer, AstraZeneca, M&A
Immunomedics' (IMMU) CEO Cynthia Sullivan on F3Q 2014 Results - Earnings Call Transcript
Seeking Alpha
Sunday, May 11, 2014 - 10:48am
tags:
Immunomedics, earnings
UK labs play shrinking role in AstraZeneca drug portfolio
Reuters
Sunday, May 11, 2014 - 10:32am
tags:
AstraZeneca, R&D
Zalicus To Be Acquired By Epirus Biopharma
Seeking Alpha
Sunday, May 11, 2014 - 10:31am
tags:
Zalicus, Epirus
Gilead Announces Results from Phase 2 Study Showing Reduction in Atrial Fibrillation Burden with the Investigational Combination of Ranolazine and Low-Dose Dronedarone
Yahoo/BusinessWire
Sunday, May 11, 2014 - 10:30am
tags:
Gilead Sciences, dronedarone, ranolazine, atrial fibrilation
Pfizer Continues to Defend Takeover Bid for AstraZeneca
NY Times
Sunday, May 11, 2014 - 10:28am
tags:
Pfizer, M&A, AstraZeneca
This Week in Biotech: Chelsea Therapeutics Finds a Buyer While Corcept Implodes
Motley Fool
Saturday, May 10, 2014 - 12:45pm
tags:
Chelsea Therapeutics, Corcept Therapeutics, Lundbeck, Theravance, GSK, AstraZeneca, Amgen
Ranbaxy posts loss after write-offs on U.S. import bans
Reuters
Saturday, May 10, 2014 - 12:20pm
tags:
Ranbaxy, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.